Latest News

10

November 2020

iX Biopharma is pleased to announce that it has received positive feedback from the European Medicines Agency (EMA) regarding its Phase 3 clinical development programme for Wafermine...

Read On

28

October 2020

The management of iX Biopharma presented at a guest webinar hosted by Phillip Securities...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com